Skip to content
Search

Latest Stories

Make scripts free during Covid crisis says RP

The Royal Pharmaceutical Society has called for all prescription charges in England to be suspended during the COVID-19 pandemic.

Making the case, Chair of the RPS in England Claire Anderson said: “During this time of crisis it’s vital for everyone to be taking the medication they need to stay well.


"We urge the government to implement this simple measure to help lift the financial burden carried by patients with long term health conditions."

The RPS has signed a letter to Lord Bethell, Parliamentary Under Secretary of State, as part of the Prescription Charges Coalition - a group of 48 charities and organisations campaigning to end prescription charges for people with long-term conditions.

It has has also raised the issue directly in weekly meetings with the Pharmacy Minister, Jo Churchill.

Arguing that around one in three people with long-term conditions skipped medicine because of cost, Anderson said: "Too many are forced to make impossible choices between buying their medicines, heating their homes or getting the food that they need. The Covid-19 pandemic has exacerbated the financial hardships of many even further.

“There should be no financial barrier between a patient and the medicines they need. We hope to see an emergency waiver on prescription charges as soon as possible and are discussing this with the Government on a weekly basis.”

Meanwhile, the statement comes when pharmacy negotiator, PSNC, has been holding talks with the government on waiving the requirement for prescriptions to be signed by a patient during the coronavirus crisis.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less